Clinical Trial Details


Back to Clinical Trials Database

Gem-(R)CHOP versus (R)CHOP : a randomized Phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's Lymphoma

Study documentation Publications

Trial Status All trial activities ended
Dates Date of activation: 26-Jan-2004
Date Step1 close: 23-Mar-2007
Data management at EORTC Yes
Design Phase 2
Randomized open
Targeted Sample size EORTC Groups: 84
Treatment Cyclophosphamide, Doxorubicin, Gemcitabine, Prednisone, Rituximab, Vincristine
Study Staff
Type of cancer
Participating groups EORTC Lymphoma Group
Participating centers
Protocol summary
NCT number NCT00079261